FusionGDB Logo

Home

Download

Statistics

Examples

Help

Contact

Center for Computational Systems Medicine
leaf

Fusion Gene Summary

leaf

Fusion Gene ORF analysis

leaf

Fusion Genomic Features

leaf

Fusion Protein Features

leaf

Fusion Gene Sequence

leaf

Fusion Gene PPI analysis

leaf

Related Drugs

leaf

Related Diseases

Fusion gene:ZNF462-VEGFA (FusionGDB2 ID:101474)

Fusion Gene Summary for ZNF462-VEGFA

check button Fusion gene summary
Fusion gene informationFusion gene name: ZNF462-VEGFA
Fusion gene ID: 101474
HgeneTgene
Gene symbol

ZNF462

VEGFA

Gene ID

58499

7422

Gene namezinc finger protein 462vascular endothelial growth factor A
SynonymsWSKA|ZFPIP|Zfp462MVCD1|VEGF|VPF
Cytomap

9q31.2

6p21.1

Type of geneprotein-codingprotein-coding
Descriptionzinc finger protein 462zinc finger PBX1-interacting proteinvascular endothelial growth factor Avascular endothelial growth factor A121vascular endothelial growth factor A165vascular permeability factor
Modification date2020031320200329
UniProtAcc..
Ensembl transtripts involved in fusion geneENST00000457913, ENST00000277225, 
ENST00000441147, ENST00000542028, 
ENST00000497489, 
ENST00000372067, 
ENST00000417285, ENST00000324450, 
ENST00000413642, ENST00000372055, 
ENST00000482630, ENST00000425836, 
ENST00000372064, ENST00000372077, 
ENST00000520948, ENST00000523873, 
ENST00000523950, ENST00000518689, 
ENST00000523125, ENST00000457104, 
ENST00000518824, ENST00000230480, 
Fusion gene scores* DoF score7 X 5 X 5=17510 X 9 X 5=450
# samples 713
** MAII scorelog2(7/175*10)=-1.32192809488736
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
log2(13/450*10)=-1.79141337818858
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Context

PubMed: ZNF462 [Title/Abstract] AND VEGFA [Title/Abstract] AND fusion [Title/Abstract]

Most frequent breakpointZNF462(109625636)-VEGFA(43742078), # samples:1
Anticipated loss of major functional domain due to fusion event.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
TgeneVEGFA

GO:0000122

negative regulation of transcription by RNA polymerase II

18093989

TgeneVEGFA

GO:0001525

angiogenesis

11427521|21771332

TgeneVEGFA

GO:0001666

response to hypoxia

16490744

TgeneVEGFA

GO:0001934

positive regulation of protein phosphorylation

18386220|19033661

TgeneVEGFA

GO:0001938

positive regulation of endothelial cell proliferation

9202027|10022831|12714610|16489009|18386220|18577655|20497126

TgeneVEGFA

GO:0002042

cell migration involved in sprouting angiogenesis

18059339|20660291

TgeneVEGFA

GO:0002092

positive regulation of receptor internalization

20660291

TgeneVEGFA

GO:0008284

positive regulation of cell proliferation

7929439

TgeneVEGFA

GO:0008360

regulation of cell shape

7929439|10527820

TgeneVEGFA

GO:0010595

positive regulation of endothelial cell migration

10022831|19033661

TgeneVEGFA

GO:0010628

positive regulation of gene expression

18386220

TgeneVEGFA

GO:0010629

negative regulation of gene expression

28977001

TgeneVEGFA

GO:0010749

regulation of nitric oxide mediated signal transduction

16150726

TgeneVEGFA

GO:0030224

monocyte differentiation

21149635

TgeneVEGFA

GO:0030225

macrophage differentiation

21149635

TgeneVEGFA

GO:0030335

positive regulation of cell migration

7929439|17470632

TgeneVEGFA

GO:0030949

positive regulation of vascular endothelial growth factor receptor signaling pathway

1312256|7929439

TgeneVEGFA

GO:0031334

positive regulation of protein complex assembly

16489009|19033661

TgeneVEGFA

GO:0031954

positive regulation of protein autophosphorylation

20497126

TgeneVEGFA

GO:0032147

activation of protein kinase activity

18059339|20497126

TgeneVEGFA

GO:0032793

positive regulation of CREB transcription factor activity

20497126

TgeneVEGFA

GO:0033138

positive regulation of peptidyl-serine phosphorylation

18440775|20497126

TgeneVEGFA

GO:0035148

tube formation

19033661

TgeneVEGFA

GO:0035767

endothelial cell chemotaxis

18440775

TgeneVEGFA

GO:0035924

cellular response to vascular endothelial growth factor stimulus

18440775|20497126

TgeneVEGFA

GO:0038033

positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway

18440775|20497126|21245381

TgeneVEGFA

GO:0038091

positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway

17470632

TgeneVEGFA

GO:0042531

positive regulation of tyrosine phosphorylation of STAT protein

19390056

TgeneVEGFA

GO:0043117

positive regulation of vascular permeability

26598555

TgeneVEGFA

GO:0043154

negative regulation of cysteine-type endopeptidase activity involved in apoptotic process

18386220

TgeneVEGFA

GO:0043406

positive regulation of MAP kinase activity

18440775

TgeneVEGFA

GO:0043536

positive regulation of blood vessel endothelial cell migration

9202027|18440775|20497126

TgeneVEGFA

GO:0045766

positive regulation of angiogenesis

18440775|18577655|19033661|20497126

TgeneVEGFA

GO:0045785

positive regulation of cell adhesion

19674970

TgeneVEGFA

GO:0045944

positive regulation of transcription by RNA polymerase II

18059339

TgeneVEGFA

GO:0048010

vascular endothelial growth factor receptor signaling pathway

21245381

TgeneVEGFA

GO:0050731

positive regulation of peptidyl-tyrosine phosphorylation

10022831|16489009|20048167|21245381|26598555

TgeneVEGFA

GO:0050918

positive chemotaxis

20497126

TgeneVEGFA

GO:0050927

positive regulation of positive chemotaxis

7929439|12744932

TgeneVEGFA

GO:0051272

positive regulation of cellular component movement

10527820|12744932

TgeneVEGFA

GO:0051894

positive regulation of focal adhesion assembly

16489009

TgeneVEGFA

GO:0071456

cellular response to hypoxia

10575000

TgeneVEGFA

GO:0090037

positive regulation of protein kinase C signaling

18059339

TgeneVEGFA

GO:0090050

positive regulation of cell migration involved in sprouting angiogenesis

20551324

TgeneVEGFA

GO:0097533

cellular stress response to acid chemical

26299712

TgeneVEGFA

GO:1900086

positive regulation of peptidyl-tyrosine autophosphorylation

20660291

TgeneVEGFA

GO:1900745

positive regulation of p38MAPK cascade

18386220

TgeneVEGFA

GO:1901727

positive regulation of histone deacetylase activity

20497126

TgeneVEGFA

GO:1903141

negative regulation of establishment of endothelial barrier

20048167

TgeneVEGFA

GO:1903392

negative regulation of adherens junction organization

26598555

TgeneVEGFA

GO:1903572

positive regulation of protein kinase D signaling

20497126

TgeneVEGFA

GO:1903672

positive regulation of sprouting angiogenesis

26299712

TgeneVEGFA

GO:2000048

negative regulation of cell-cell adhesion mediated by cadherin

26598555


check buttonFusion gene breakpoints across ZNF462 (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check buttonFusion gene breakpoints across VEGFA (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.

check button Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0)
* All genome coordinats were lifted-over on hg19.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
SourceDiseaseSampleHgeneHchrHbpHstrandTgeneTchrTbpTstrand
ChimerDB4BRCATCGA-AR-A24Q-01AZNF462chr9

109625636

+VEGFAchr6

43742078

+


Top

Fusion Gene ORF analysis for ZNF462-VEGFA

check button Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure.
* Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser.
ORFHenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrand
5UTR-3CDSENST00000457913ENST00000372067ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000417285ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000324450ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000413642ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000372055ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000482630ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000425836ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000372064ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000372077ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000520948ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000523873ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000523950ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000518689ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000523125ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000457104ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000457913ENST00000518824ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-5UTRENST00000457913ENST00000230480ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000372067ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000417285ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000324450ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000413642ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000372055ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000482630ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000425836ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000372064ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000372077ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000520948ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000523873ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000523950ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000518689ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000523125ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000457104ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-3CDSENST00000277225ENST00000518824ZNF462chr9

109625636

+VEGFAchr6

43742078

+
5UTR-5UTRENST00000277225ENST00000230480ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000372067ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000417285ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000324450ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000413642ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000372055ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000482630ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000425836ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000372064ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000372077ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000520948ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000523873ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000523950ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000518689ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000523125ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000457104ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000441147ENST00000518824ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-5UTRENST00000441147ENST00000230480ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000372067ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000417285ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000324450ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000413642ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000372055ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000482630ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000425836ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000372064ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000372077ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000520948ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000523873ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000523950ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000518689ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000523125ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000457104ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000542028ENST00000518824ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-5UTRENST00000542028ENST00000230480ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000372067ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000417285ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000324450ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000413642ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000372055ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000482630ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000425836ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000372064ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000372077ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000520948ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000523873ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000523950ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000518689ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000523125ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000457104ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-3CDSENST00000497489ENST00000518824ZNF462chr9

109625636

+VEGFAchr6

43742078

+
intron-5UTRENST00000497489ENST00000230480ZNF462chr9

109625636

+VEGFAchr6

43742078

+

check buttonORFfinder result based on the fusion transcript sequence of in-frame fusion genes.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score

Top

Fusion Genomic Features for ZNF462-VEGFA


check buttonFusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints.
HgeneHchrHbpHstrandTgeneTchrTbpTstrand1-pp (fusion gene breakpoint)
ZNF462chr9109625636+VEGFAchr643742077+0.0166273470.9833726
ZNF462chr9109625636+VEGFAchr643742077+0.0166273470.9833726

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page.

check buttonDistribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page.

Top

Fusion Protein Features for ZNF462-VEGFA


check button Go to

FGviewer for the breakpoints of :-:

.
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
FGviewer

check buttonMain function of each fusion partner protein. (from UniProt)
HgeneTgene
..
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at

download page


* Minus value of BPloci means that the break pointn is located before the CDS.
- In-frame and retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

- In-frame and not-retained protein feature among the 13 regional features.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note


Top

Fusion Gene Sequence for ZNF462-VEGFA


check button For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones.

Top

Fusion Gene PPI Analysis for ZNF462-VEGFA


check button Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in

ChiPPI page.


check button Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160)
HgeneHgene's interactorsTgeneTgene's interactors


check button - Retained PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenStill interaction with


check button - Lost PPIs in in-frame fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


check button - Retained PPIs, but lost function due to frame-shift fusion.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenInteraction lost with


Top

Related Drugs for ZNF462-VEGFA


check button Drugs targeting genes involved in this fusion gene.
(DrugBank Version 5.1.8 2021-05-08)
PartnerGeneUniProtAccDrugBank IDDrug nameDrug activityDrug typeDrug status

Top

Related Diseases for ZNF462-VEGFA


check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
HgeneZNF462C0004238Atrial Fibrillation1CTD_human
HgeneZNF462C0005745Blepharoptosis1GENOMICS_ENGLAND
HgeneZNF462C0007131Non-Small Cell Lung Carcinoma1CTD_human
HgeneZNF462C0010278Craniosynostosis1GENOMICS_ENGLAND
HgeneZNF462C0033377Ptosis1GENOMICS_ENGLAND
HgeneZNF462C0235480Paroxysmal atrial fibrillation1CTD_human
HgeneZNF462C0557874Global developmental delay1GENOMICS_ENGLAND
HgeneZNF462C0856975Autistic behavior1GENOMICS_ENGLAND
HgeneZNF462C1857949Prominent metopic ridge1GENOMICS_ENGLAND
HgeneZNF462C2585653Persistent atrial fibrillation1CTD_human
HgeneZNF462C3468561familial atrial fibrillation1CTD_human
HgeneZNF462C3714756Intellectual Disability1GENOMICS_ENGLAND
TgeneVEGFAC0011570Mental Depression5PSYGENET
TgeneVEGFAC0011581Depressive disorder5PSYGENET
TgeneVEGFAC0151744Myocardial Ischemia5CTD_human
TgeneVEGFAC1269683Major Depressive Disorder5PSYGENET
TgeneVEGFAC0033578Prostatic Neoplasms4CTD_human
TgeneVEGFAC0376358Malignant neoplasm of prostate4CTD_human
TgeneVEGFAC0004096Asthma3CTD_human
TgeneVEGFAC0011884Diabetic Retinopathy3CTD_human
TgeneVEGFAC0027627Neoplasm Metastasis3CTD_human
TgeneVEGFAC0027659Neoplasms, Experimental3CTD_human
TgeneVEGFAC0003865Arthritis, Adjuvant-Induced2CTD_human
TgeneVEGFAC0005586Bipolar Disorder2PSYGENET
TgeneVEGFAC0007137Squamous cell carcinoma2CTD_human
TgeneVEGFAC0010054Coronary Arteriosclerosis2CTD_human
TgeneVEGFAC0018801Heart failure2CTD_human
TgeneVEGFAC0018802Congestive heart failure2CTD_human
TgeneVEGFAC0022660Kidney Failure, Acute2CTD_human
TgeneVEGFAC0023212Left-Sided Heart Failure2CTD_human
TgeneVEGFAC0023893Liver Cirrhosis, Experimental2CTD_human
TgeneVEGFAC0027686Pathologic Neovascularization2CTD_human
TgeneVEGFAC0235527Heart Failure, Right-Sided2CTD_human
TgeneVEGFAC0525045Mood Disorders2PSYGENET
TgeneVEGFAC0971858Arthritis, Collagen-Induced2CTD_human
TgeneVEGFAC0993582Arthritis, Experimental2CTD_human
TgeneVEGFAC1565662Acute Kidney Insufficiency2CTD_human
TgeneVEGFAC1956346Coronary Artery Disease2CTD_human
TgeneVEGFAC1959583Myocardial Failure2CTD_human
TgeneVEGFAC1961112Heart Decompensation2CTD_human
TgeneVEGFAC2609414Acute kidney injury2CTD_human
TgeneVEGFAC0001418Adenocarcinoma1CTD_human
TgeneVEGFAC0002152Alloxan Diabetes1CTD_human
TgeneVEGFAC0002395Alzheimer's Disease1CTD_human
TgeneVEGFAC0003873Rheumatoid Arthritis1CTD_human
TgeneVEGFAC0004153Atherosclerosis1CTD_human
TgeneVEGFAC0006118Brain Neoplasms1CTD_human
TgeneVEGFAC0006826Malignant Neoplasms1CTD_human
TgeneVEGFAC0007102Malignant tumor of colon1CTD_human
TgeneVEGFAC0007131Non-Small Cell Lung Carcinoma1CTD_human
TgeneVEGFAC0007873Uterine Cervical Neoplasm1CTD_human
TgeneVEGFAC0008677Bronchitis, Chronic1CTD_human
TgeneVEGFAC0009375Colonic Neoplasms1CTD_human
TgeneVEGFAC0010398Cruveilhier-Baumgarten Syndrome1CTD_human
TgeneVEGFAC0011265Presenile dementia1CTD_human
TgeneVEGFAC0011616Contact Dermatitis1CTD_human
TgeneVEGFAC0011853Diabetes Mellitus, Experimental1CTD_human
TgeneVEGFAC0011881Diabetic Nephropathy1CTD_human
TgeneVEGFAC0013366Dyschondroplasias1CTD_human
TgeneVEGFAC0014170Endometrial Neoplasms1CTD_human
TgeneVEGFAC0014556Epilepsy, Temporal Lobe1CTD_human
TgeneVEGFAC0014558Uncinate Epilepsy1CTD_human
TgeneVEGFAC0017636Glioblastoma1CTD_human
TgeneVEGFAC0017667Nodular glomerulosclerosis1CTD_human
TgeneVEGFAC0018671Head and Neck Neoplasms1CTD_human
TgeneVEGFAC0018675Head Neoplasms1CTD_human
TgeneVEGFAC0018798Congenital Heart Defects1CTD_human
TgeneVEGFAC0018799Heart Diseases1CTD_human
TgeneVEGFAC0018923Hemangiosarcoma1CTD_human
TgeneVEGFAC0019193Hepatitis, Toxic1CTD_human
TgeneVEGFAC0020541Portal Hypertension1CTD_human
TgeneVEGFAC0021368Inflammation1CTD_human
TgeneVEGFAC0023186Learning Disorders1CTD_human
TgeneVEGFAC0023466Leukemia, Monocytic, Chronic1CTD_human
TgeneVEGFAC0023470Myeloid Leukemia1CTD_human
TgeneVEGFAC0023890Liver Cirrhosis1CTD_human
TgeneVEGFAC0024115Lung diseases1CTD_human
TgeneVEGFAC0024440Macular Edema, Cystoid1CTD_human
TgeneVEGFAC0025237Melnick-Needles Syndrome1CTD_human
TgeneVEGFAC0025261Memory Disorders1CTD_human
TgeneVEGFAC0026760Multiple Epiphyseal Dysplasia1CTD_human
TgeneVEGFAC0027055Myocardial Reperfusion Injury1CTD_human
TgeneVEGFAC0027533Neck Neoplasms1CTD_human
TgeneVEGFAC0027643Neoplasm Recurrence, Local1CTD_human
TgeneVEGFAC0027651Neoplasms1CTD_human
TgeneVEGFAC0029422Osteochondrodysplasias1CTD_human
TgeneVEGFAC0029463Osteosarcoma1CTD_human
TgeneVEGFAC0030246Pustulosis of Palms and Soles1CTD_human
TgeneVEGFAC0032927Precancerous Conditions1CTD_human
TgeneVEGFAC0033687Proteinuria1CTD_human
TgeneVEGFAC0033860Psoriasis1CTD_human
TgeneVEGFAC0035228Respiratory Hypersensitivity1CTD_human
TgeneVEGFAC0035309Retinal Diseases1CTD_human
TgeneVEGFAC0035328Retinal Vein Occlusion1CTD_human
TgeneVEGFAC0035412Rhabdomyosarcoma1CTD_human
TgeneVEGFAC0036391Schwartz-Jampel Syndrome1CTD_human
TgeneVEGFAC0038015Spondyloepiphyseal Dysplasia1CTD_human
TgeneVEGFAC0038220Status Epilepticus1CTD_human
TgeneVEGFAC0038358Gastric ulcer1CTD_human
TgeneVEGFAC0038433Streptozotocin Diabetes1CTD_human
TgeneVEGFAC0042076Urologic Neoplasms1CTD_human
TgeneVEGFAC0085109Corneal Neovascularization1CTD_human
TgeneVEGFAC0085605Liver Failure1CTD_human
TgeneVEGFAC0086692Benign Neoplasm1CTD_human
TgeneVEGFAC0153633Malignant neoplasm of brain1CTD_human
TgeneVEGFAC0162351Contact hypersensitivity1CTD_human
TgeneVEGFAC0178540Cerebral Hypoxia-Ischemia1CTD_human
TgeneVEGFAC0205641Adenocarcinoma, Basal Cell1CTD_human
TgeneVEGFAC0205642Adenocarcinoma, Oxyphilic1CTD_human
TgeneVEGFAC0205643Carcinoma, Cribriform1CTD_human
TgeneVEGFAC0205644Carcinoma, Granular Cell1CTD_human
TgeneVEGFAC0205645Adenocarcinoma, Tubular1CTD_human
TgeneVEGFAC0206726gliosarcoma1CTD_human
TgeneVEGFAC0233794Memory impairment1CTD_human
TgeneVEGFAC0239946Fibrosis, Liver1CTD_human
TgeneVEGFAC0242350Erectile dysfunction1CTD_human
TgeneVEGFAC0242383Age related macular degeneration1CTD_human
TgeneVEGFAC0270823Petit mal status1CTD_human
TgeneVEGFAC0271051Macular retinal edema1CTD_human
TgeneVEGFAC0271178Irvine-Gass Syndrome1CTD_human
TgeneVEGFAC0276496Familial Alzheimer Disease (FAD)1CTD_human
TgeneVEGFAC0278996Malignant Head and Neck Neoplasm1CTD_human
TgeneVEGFAC0282313Condition, Preneoplastic1CTD_human
TgeneVEGFAC0311335Grand Mal Status Epilepticus1CTD_human
TgeneVEGFAC0334588Giant Cell Glioblastoma1CTD_human
TgeneVEGFAC0342257Complications of Diabetes Mellitus1CTD_human
TgeneVEGFAC0393672Epilepsy, Benign Psychomotor, Childhood1CTD_human
TgeneVEGFAC0393682Epilepsy, Lateral Temporal1CTD_human
TgeneVEGFAC0393734Complex Partial Status Epilepticus1CTD_human
TgeneVEGFAC0432272Van Buchem disease1CTD_human
TgeneVEGFAC0476089Endometrial Carcinoma1CTD_human
TgeneVEGFAC0494463Alzheimer Disease, Late Onset1CTD_human
TgeneVEGFAC0496899Benign neoplasm of brain, unspecified1CTD_human
TgeneVEGFAC0546126Acute Confusional Senile Dementia1CTD_human
TgeneVEGFAC0600518Choroidal Neovascularization1CTD_human
TgeneVEGFAC0678807prenatal alcohol exposure1PSYGENET
TgeneVEGFAC0746787Cancer of Neck1CTD_human
TgeneVEGFAC0750900Alzheimer's Disease, Focal Onset1CTD_human
TgeneVEGFAC0750901Alzheimer Disease, Early Onset1CTD_human
TgeneVEGFAC0750974Brain Tumor, Primary1CTD_human
TgeneVEGFAC0750977Recurrent Brain Neoplasm1CTD_human
TgeneVEGFAC0750979Primary malignant neoplasm of brain1CTD_human
TgeneVEGFAC0751177Cancer of Head1CTD_human
TgeneVEGFAC0751262Adult Learning Disorders1CTD_human
TgeneVEGFAC0751263Learning Disturbance1CTD_human
TgeneVEGFAC0751265Learning Disabilities1CTD_human
TgeneVEGFAC0751292Age-Related Memory Disorders1CTD_human
TgeneVEGFAC0751293Memory Disorder, Semantic1CTD_human
TgeneVEGFAC0751294Memory Disorder, Spatial1CTD_human
TgeneVEGFAC0751295Memory Loss1CTD_human
TgeneVEGFAC0751522Status Epilepticus, Subclinical1CTD_human
TgeneVEGFAC0751523Non-Convulsive Status Epilepticus1CTD_human
TgeneVEGFAC0751524Simple Partial Status Epilepticus1CTD_human
TgeneVEGFAC0751571Cancer of Urinary Tract1CTD_human
TgeneVEGFAC0752304Hypoxic-Ischemic Encephalopathy1CTD_human
TgeneVEGFAC0752305Anoxic-Ischemic Encephalopathy1CTD_human
TgeneVEGFAC0752306Anoxia-Ischemia, Brain1CTD_human
TgeneVEGFAC0752307Anoxia-Ischemia, Cerebral1CTD_human
TgeneVEGFAC0752308Hypoxia-Ischemia, Brain1CTD_human
TgeneVEGFAC0860207Drug-Induced Liver Disease1CTD_human
TgeneVEGFAC0887833Carcinoma, Pancreatic Ductal1CTD_human
TgeneVEGFAC0887900Upper Aerodigestive Tract Neoplasms1CTD_human
TgeneVEGFAC1262760Hepatitis, Drug-Induced1CTD_human
TgeneVEGFAC1330966Developmental Academic Disorder1CTD_human
TgeneVEGFAC1527390Neoplasms, Intracranial1CTD_human
TgeneVEGFAC1527411Thrombosis of retinal vein1CTD_human
TgeneVEGFAC1563937Atherogenesis1CTD_human
TgeneVEGFAC1621958Glioblastoma Multiforme1CTD_human
TgeneVEGFAC2063866Depressive Disorder, Treatment-Resistant1PSYGENET
TgeneVEGFAC2717961Thrombotic Microangiopathies1CTD_human
TgeneVEGFAC2931852Clear-cell metastatic renal cell carcinoma1CTD_human
TgeneVEGFAC2937358Cerebral Hemorrhage1CTD_human
TgeneVEGFAC3541456Spondyloepiphyseal Dysplasia Tarda, X-Linked1CTD_human
TgeneVEGFAC3658290Drug-Induced Acute Liver Injury1CTD_human
TgeneVEGFAC4048328cervical cancer1CTD_human
TgeneVEGFAC4277682Chemical and Drug Induced Liver Injury1CTD_human
TgeneVEGFAC4279912Chemically-Induced Liver Toxicity1CTD_human
TgeneVEGFAC4551479Schwartz-Jampel Syndrome, Type 11CTD_human